{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:29:53Z","timestamp":1791224993542,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["GA 309449"],"award-info":[{"award-number":["GA 309449"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union's Seventh Framework Programme","award":["241779"],"award-info":[{"award-number":["241779"]}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.coi.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T22:03:14Z","timestamp":1414620194000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"special_numbering":"C","title":["Type I interferonopathies: Mendelian type I interferon up-regulation"],"prefix":"10.1016","volume":"32","author":[{"given":"Yanick J","family":"Crow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2014.10.005_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1980.tb20602.x","article-title":"Interferon-induced disease in mice and rats","volume":"350","author":"Gresser","year":"1980","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coi.2014.10.005_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2014.10.005_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(88)90125-6","article-title":"Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy","volume":"84","author":"Lebon","year":"1988","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coi.2014.10.005_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2014.10.005_bib0025","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1093\/hmg\/ddp293","article-title":"Aicardi\u2013Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity","volume":"18","author":"Crow","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coi.2014.10.005_sbref0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","article-title":"Cytosolic sensing of viruses","volume":"38","author":"Goubau","year":"2013","journal-title":"Immunity"},{"issue":"Pt 1","key":"10.1016\/j.coi.2014.10.005_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.coi.2014.10.005_sbref0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/embj.201386117","article-title":"RNA:DNA hybrids are a novel molecular pattern sensed by TLR9","volume":"33","author":"Rigby","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2014.10.005_sbref0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2014.10.005_sbref0055","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2014.10.005_sbref0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2013.10.010","article-title":"STING-dependent cytosolic DNA sensing pathways","volume":"35","author":"Barber","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2014.10.005_bib0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3\u2032\u20135\u2032 DNA exonuclease TREX1 cause Aicardi\u2013Goutieres syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0070","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi\u2013Goutieres syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi\u2013Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_sbref0080","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","author":"Ryoo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2014.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi\u2013Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_sbref0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajhg.2014.06.007","article-title":"Aicardi\u2013Goutieres syndrome is caused by IFIH1 mutations","volume":"95","author":"Oda","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"Suppl. A","key":"10.1016\/j.coi.2014.10.005_bib0100","doi-asserted-by":"crossref","first-page":"A47","DOI":"10.1053\/ejpn.2002.0574","article-title":"Aicardi\u2013Goutieres syndrome","volume":"6","author":"Lebon","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.coi.2014.10.005_sbref0105","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi\u2013Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case\u2013control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2014.10.005_bib0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.coi.2014.10.005_sbref0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ni.2872","article-title":"The enemy within: endogenous retroelements and autoimmune disease","volume":"15","author":"Volkman","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2014.10.005_bib0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.coi.2014.10.005_bib0125","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1093\/hmg\/ddu319","article-title":"Altered spatio-temporal dynamics of RNase H2 complex assembly at replication and repair sites in Aicardi\u2013Goutieres syndrome","volume":"23","author":"Kind","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2014.10.005_bib0135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2014.10.005_bib0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ni.1941","article-title":"The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1","volume":"11","author":"Yan","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2014.10.005_sbref0145","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cell.2012.04.011","article-title":"Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development","volume":"149","author":"Reijns","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.coi.2014.10.005_bib0150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20120876","article-title":"Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity","volume":"209","author":"Hiller","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2014.10.005_sbref0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","article-title":"A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1","volume":"51","author":"Livingston","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.coi.2014.10.005_sbref0160","article-title":"Mutations in ADAR1, IFIH1 and RNASEH2B presenting as spastic paraplegia","author":"Crow","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.coi.2014.10.005_sbref0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2014.10.005_bib0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.a.35712","article-title":"Striking intrafamilial phenotypic variability in Aicardi\u2013Goutieres syndrome associated with the recurrent Asian founder mutation in RNASEH2C","volume":"161A","author":"Vogt","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.coi.2014.10.005_sbref0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","article-title":"Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease","volume":"36","author":"Gall","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2014.10.005_bib0180","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.1400737","article-title":"TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner","volume":"192","author":"Ablasser","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2014.10.005_bib0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2014.10.005_bib0195","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0961203313486950","article-title":"Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy","volume":"22","author":"Troedson","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.coi.2014.10.005_bib0200","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/art.24852","article-title":"C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis","volume":"60","author":"Lood","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2014.10.005_bib0205","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.4049\/jimmunol.1001731","article-title":"C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes","volume":"185","author":"Santer","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2014.10.005_bib0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","article-title":"Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress","volume":"142","author":"Seifert","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.coi.2014.10.005_bib0215","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2014.10.005_bib0220","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous Candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2014.10.005_bib0225","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.161.9.5016","article-title":"Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration","volume":"161","author":"Akwa","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2014.10.005_bib0230","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","article-title":"Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing","volume":"39","author":"Gehrke","year":"2013","journal-title":"Immunity"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791514001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791514001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:38:53Z","timestamp":1760603933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791514001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":46,"alternative-id":["S0952791514001290"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2014.10.005","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferonopathies: Mendelian type I interferon up-regulation","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}